Soleus Capital Management as of March 31, 2020
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 48 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Essa Pharma (EPIX) | 9.7 | $8.3M | 2.1M | 4.00 | |
| Grifols S A Sponsored Adr R (GRFS) | 9.1 | $7.8M | 387k | 20.14 | |
| Iveric Bio | 6.4 | $5.5M | 1.6M | 3.44 | |
| Harpoon Therapeutics | 6.3 | $5.5M | 471k | 11.58 | |
| Iradimed (IRMD) | 5.8 | $5.0M | 235k | 21.35 | |
| Alexion Pharmaceuticals | 5.0 | $4.3M | 48k | 89.79 | |
| Zynex (ZYXI) | 4.5 | $3.9M | 349k | 11.07 | |
| Dex (DXCM) | 4.2 | $3.6M | 14k | 269.29 | |
| Vericel (VCEL) | 3.8 | $3.2M | 352k | 9.17 | |
| Adverum Biotechnologies | 3.6 | $3.1M | 314k | 9.77 | |
| Eiger Biopharmaceuticals | 3.2 | $2.8M | 405k | 6.80 | |
| Allergan | 3.0 | $2.6M | 15k | 177.12 | |
| Aeglea Biotherapeutics | 2.9 | $2.5M | 537k | 4.66 | |
| Misonix | 2.6 | $2.2M | 238k | 9.42 | |
| Zymeworks | 2.5 | $2.2M | 62k | 35.46 | |
| Antares Pharma | 2.4 | $2.0M | 864k | 2.36 | |
| Abbvie (ABBV) | 2.3 | $2.0M | 27k | 76.19 | |
| UnitedHealth (UNH) | 2.3 | $2.0M | 7.9k | 249.37 | |
| Axonics Modulation Technolog (AXNX) | 1.9 | $1.6M | 63k | 25.41 | |
| Itamar Med | 1.6 | $1.4M | 115k | 11.78 | |
| Rafael Hldgs (RFL) | 1.3 | $1.1M | 89k | 12.81 | |
| Kadmon Hldgs | 1.3 | $1.1M | 257k | 4.19 | |
| Zafgen | 1.2 | $1.0M | 1.3M | 0.77 | |
| Biogen Idec (BIIB) | 1.1 | $949k | 3.0k | 316.33 | |
| Establishment Labs Holdings Ord (ESTA) | 1.1 | $914k | 63k | 14.45 | |
| Axogen (AXGN) | 0.9 | $781k | 75k | 10.41 | |
| Millendo Therapeutics | 0.9 | $778k | 147k | 5.28 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $727k | 16k | 44.60 | |
| Crispr Therapeutics (CRSP) | 0.8 | $696k | 16k | 42.44 | |
| Amicus Therapeutics (FOLD) | 0.8 | $665k | 72k | 9.24 | |
| Constellation Pharmceticls I | 0.7 | $563k | 18k | 31.45 | |
| Enanta Pharmaceuticals (ENTA) | 0.6 | $545k | 11k | 51.42 | |
| Cytosorbents (CTSO) | 0.6 | $538k | 70k | 7.73 | |
| Livongo Health | 0.6 | $516k | 18k | 28.51 | |
| Shockwave Med (SWAV) | 0.5 | $404k | 12k | 33.16 | |
| Novocure Ltd ord (NVCR) | 0.4 | $377k | 5.6k | 67.36 | |
| Relmada Therapeutics (RLMD) | 0.4 | $375k | 11k | 34.09 | |
| Amarin Corporation (AMRN) | 0.4 | $360k | 90k | 4.00 | |
| STAAR Surgical Company (STAA) | 0.3 | $252k | 7.8k | 32.32 | |
| Tcr2 Therapeutics Inc cs | 0.3 | $237k | 31k | 7.74 | |
| Pacira Pharmaceuticals (PCRX) | 0.3 | $235k | 7.0k | 33.57 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $230k | 21k | 10.96 | |
| Aduro Biotech | 0.3 | $222k | 81k | 2.73 | |
| Aytu Bioscience | 0.2 | $209k | 140k | 1.50 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $197k | 19k | 10.37 | |
| Revance Therapeutics (RVNC) | 0.2 | $176k | 12k | 14.83 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $150k | 13k | 11.34 | |
| Insmed Inc convertible security | 0.2 | $150k | 180k | 0.83 |
